Saint Francis Medical Center | |
211 St Francis Dr, Cape Girardeau, Missouri 63703 | |
(573) 331-3000 | |
Name | Saint Francis Medical Center |
---|---|
Type | Acute Care Hospital |
Location | 211 St Francis Dr, Cape Girardeau, Missouri |
Ownership | Voluntary non-profit - Church |
Emergency Services | Yes |
Medicare ID (CCN) | 260183 |
NPI Number | 1467412726 |
Organization Name | SAINT FRANCIS MEDICAL CENTER |
Address | 211 St Francis Drive, Cape Girardeau, MO 63703 |
Hospital Type | General Acute Care Hospital |
Phone Number | 573-331-3080 |
News Archive
Celator Pharmaceuticals today announced that it has completed enrollment in its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML).
Generex Biotechnology Corporation today announced that the Company, together with Global Medical Direct, Inc. and its stockholders, have mutually decided not to proceed with the Company's previously announced acquisition of a 51% interest in GMD.
Even short, single antibiotic courses given to young animals can predispose them to inflammatory bowel disease (IBD) when they are older, according to Rutgers researchers.
The Ensign Group, Inc., the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, announced that a group of its real estate holding subsidiaries has placed mortgages on six of the Company's 27 unencumbered properties to secure a $40 million five-year term loan from GE Capital's Healthcare Financial Services business.
Protectus Medical Devices, Inc. ("Protectus Medical Devices"), a developer and marketer of innovative medical devices, today announced the signing of a three-year manufacturing agreement with Moll Industries, Inc. to provide injection molded plastic manufacturing services for the Protectus Safety Syringe.
› Verified 5 days ago
NPI Number | 1629000740 |
Organization Name | SAINT FRANCIS MEDICAL CENTER |
Address | 211 Saint Francis Dr, Cape Girardeau, MO 63703 |
Hospital Type | Rehabilitation Hospital |
Phone Number | 573-331-5228 |
News Archive
Celator Pharmaceuticals today announced that it has completed enrollment in its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML).
Generex Biotechnology Corporation today announced that the Company, together with Global Medical Direct, Inc. and its stockholders, have mutually decided not to proceed with the Company's previously announced acquisition of a 51% interest in GMD.
Even short, single antibiotic courses given to young animals can predispose them to inflammatory bowel disease (IBD) when they are older, according to Rutgers researchers.
The Ensign Group, Inc., the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, announced that a group of its real estate holding subsidiaries has placed mortgages on six of the Company's 27 unencumbered properties to secure a $40 million five-year term loan from GE Capital's Healthcare Financial Services business.
Protectus Medical Devices, Inc. ("Protectus Medical Devices"), a developer and marketer of innovative medical devices, today announced the signing of a three-year manufacturing agreement with Moll Industries, Inc. to provide injection molded plastic manufacturing services for the Protectus Safety Syringe.
› Verified 5 days ago
NPI Number | 1629052063 |
Organization Name | MEDICAL SPECIALISTS OF SOUTHEAST MISSOURI, PC |
Address | 211 Saint Francis Dr, Attn Infectious Disease Dept, Cape Girardeau, MO 63703 |
Hospital Type | General Acute Care Hospital |
Phone Number | 573-331-3000 |
News Archive
Celator Pharmaceuticals today announced that it has completed enrollment in its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML).
Generex Biotechnology Corporation today announced that the Company, together with Global Medical Direct, Inc. and its stockholders, have mutually decided not to proceed with the Company's previously announced acquisition of a 51% interest in GMD.
Even short, single antibiotic courses given to young animals can predispose them to inflammatory bowel disease (IBD) when they are older, according to Rutgers researchers.
The Ensign Group, Inc., the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, announced that a group of its real estate holding subsidiaries has placed mortgages on six of the Company's 27 unencumbered properties to secure a $40 million five-year term loan from GE Capital's Healthcare Financial Services business.
Protectus Medical Devices, Inc. ("Protectus Medical Devices"), a developer and marketer of innovative medical devices, today announced the signing of a three-year manufacturing agreement with Moll Industries, Inc. to provide injection molded plastic manufacturing services for the Protectus Safety Syringe.
› Verified 5 days ago
NPI Number | 1831523695 |
Organization Name | SAINT FRANCIS MEDICAL CENTER |
Address | 150 South Mount Auburn Road, Suite 342, Cape Girardeau, MO 63703 |
Hospital Type | General Acute Care Hospital |
Phone Number | 573-331-5787 |
News Archive
Celator Pharmaceuticals today announced that it has completed enrollment in its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML).
Generex Biotechnology Corporation today announced that the Company, together with Global Medical Direct, Inc. and its stockholders, have mutually decided not to proceed with the Company's previously announced acquisition of a 51% interest in GMD.
Even short, single antibiotic courses given to young animals can predispose them to inflammatory bowel disease (IBD) when they are older, according to Rutgers researchers.
The Ensign Group, Inc., the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, announced that a group of its real estate holding subsidiaries has placed mortgages on six of the Company's 27 unencumbered properties to secure a $40 million five-year term loan from GE Capital's Healthcare Financial Services business.
Protectus Medical Devices, Inc. ("Protectus Medical Devices"), a developer and marketer of innovative medical devices, today announced the signing of a three-year manufacturing agreement with Moll Industries, Inc. to provide injection molded plastic manufacturing services for the Protectus Safety Syringe.
› Verified 5 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Celator Pharmaceuticals today announced that it has completed enrollment in its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML).
Generex Biotechnology Corporation today announced that the Company, together with Global Medical Direct, Inc. and its stockholders, have mutually decided not to proceed with the Company's previously announced acquisition of a 51% interest in GMD.
Even short, single antibiotic courses given to young animals can predispose them to inflammatory bowel disease (IBD) when they are older, according to Rutgers researchers.
The Ensign Group, Inc., the parent company of the Ensign(TM) group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, announced that a group of its real estate holding subsidiaries has placed mortgages on six of the Company's 27 unencumbered properties to secure a $40 million five-year term loan from GE Capital's Healthcare Financial Services business.
Protectus Medical Devices, Inc. ("Protectus Medical Devices"), a developer and marketer of innovative medical devices, today announced the signing of a three-year manufacturing agreement with Moll Industries, Inc. to provide injection molded plastic manufacturing services for the Protectus Safety Syringe.
› Verified 5 days ago
Southeasthealth Acute Care Hospital Location: 1701 Lacey St, Cape Girardeau, Missouri 63701 Phone: (573) 334-4822 | |
Saint Francis Medical Center Acute Care Hospital Location: 211 St Francis Dr, Cape Girardeau, Missouri 63703 Phone: (573) 331-3000 |